BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36961010)

  • 21. Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience.
    Anselmi M; Catalucci A; Felli V; Vellucci V; Di Sibio A; Gravina GL; Di Staso M; Di Cesare E; Masciocchi C
    Neuroradiol J; 2017 Jun; 30(3):240-252. PubMed ID: 28627984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
    Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
    Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Image-fusion of MR spectroscopic images for treatment planning of gliomas.
    Chang J; Thakur S; Perera G; Kowalski A; Huang W; Karimi S; Hunt M; Koutcher J; Fuks Z; Amols H; Narayana A
    Med Phys; 2006 Jan; 33(1):32-40. PubMed ID: 16485406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging.
    Law M; Hamburger M; Johnson G; Inglese M; Londono A; Golfinos J; Zagzag D; Knopp EA
    Technol Cancer Res Treat; 2004 Dec; 3(6):557-65. PubMed ID: 15560713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving the utility of
    Crain ID; Elias PS; Chapple K; Scheck AC; Karis JP; Preul MC
    J Neurooncol; 2017 May; 133(1):97-105. PubMed ID: 28555423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-grade glioma: correlation of short echo time 1H-MR spectroscopy with 23Na MR imaging.
    Bartha R; Megyesi JF; Watling CJ
    AJNR Am J Neuroradiol; 2008 Mar; 29(3):464-70. PubMed ID: 18238848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Association between Whole-Brain MR Spectroscopy and IDH Mutation Status in Gliomas.
    Goryawala M; Saraf-Lavi E; Nagornaya N; Heros D; Komotar R; Maudsley AA
    J Neuroimaging; 2020 Jan; 30(1):58-64. PubMed ID: 31868291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive evaluation of cerebral glioma grade by using diffusion-weighted imaging-guided single-voxel proton magnetic resonance spectroscopy.
    Liu ZL; Zhou Q; Zeng QS; Li CF; Zhang K
    J Int Med Res; 2012; 40(1):76-84. PubMed ID: 22429347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases.
    Preul MC; Leblanc R; Caramanos Z; Kasrai R; Narayanan S; Arnold DL
    Can J Neurol Sci; 1998 Feb; 25(1):13-22. PubMed ID: 9532276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between Short and Long Echo Time Magnetic Resonance Spectroscopic Imaging at 3T and 7T for Evaluating Brain Metabolites in Patients with Glioma.
    Li Y; Lafontaine M; Chang S; Nelson SJ
    ACS Chem Neurosci; 2018 Jan; 9(1):130-137. PubMed ID: 29035503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging.
    Su C; Liu C; Zhao L; Jiang J; Zhang J; Li S; Zhu W; Wang J
    AJNR Am J Neuroradiol; 2017 Sep; 38(9):1702-1709. PubMed ID: 28729292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
    Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y
    Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton magnetic resonance spectroscopic imaging of cerebral gliomas: correlation of metabolite ratios with histopathologic grading.
    Hsu YY; Chang CN; Wie KJ; Lim KE; Hsu WC; Jung SM
    Chang Gung Med J; 2004 Jun; 27(6):399-407. PubMed ID: 15455540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients.
    Li X; Lu Y; Pirzkall A; McKnight T; Nelson SJ
    J Magn Reson Imaging; 2002 Sep; 16(3):229-37. PubMed ID: 12205577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.
    Stadlbauer A; Buchfelder M; Doelken MT; Hammen T; Ganslandt O
    Cent Eur Neurosurg; 2011 May; 72(2):63-9. PubMed ID: 20635312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the relation between MR spectroscopy features and the distance to MRI-visible solid tumor in GBM patients.
    Pedrosa de Barros N; Meier R; Pletscher M; Stettler S; Knecht U; Herrmann E; Schucht P; Reyes M; Gralla J; Wiest R; Slotboom J
    Magn Reson Med; 2018 Dec; 80(6):2339-2355. PubMed ID: 29893995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
    Deviers A; Ken S; Filleron T; Rowland B; Laruelo A; Catalaa I; Lubrano V; Celsis P; Berry I; Mogicato G; Cohen-Jonathan Moyal E; Laprie A
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):385-93. PubMed ID: 25104068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.